Agendia Nets Highest Level Evidence for MammaPrint Use to Predict Breast Cancer Chemotherapy Benefit Genomeweb, 18 Apr 2016 NEW YORK (GenomeWeb) – Based on the results of a large, prospective, randomized trial, researchers have found that women with…
